FNV.TO vs. BSX
FNV.TO (Franco-Nevada Corporation) and BSX (Boston Scientific Corporation) are both stocks. FNV.TO operates in Gold (Basic Materials), while BSX operates in Medical Devices (Healthcare). Over the past 10 years, FNV.TO returned 13.77%/yr vs 8.35%/yr for BSX. At a 0.05 correlation, their price movements are largely independent.
Performance
FNV.TO vs. BSX - Performance Comparison
Loading charts...
Different Trading Currencies
FNV.TO is traded in CAD, while BSX is traded in USD. To make them comparable, the BSX values have been converted to CAD using the latest available exchange rates.
Returns By Period
In the year-to-date period, FNV.TO achieves a 3.49% return, which is significantly higher than BSX's -49.75% return. Over the past 10 years, FNV.TO has outperformed BSX with an annualized return of 13.77%, while BSX has yielded a comparatively lower 8.35% annualized return.
FNV.TO
- 1D
- 1.09%
- 1M
- -10.89%
- YTD
- 3.49%
- 6M
- -0.42%
- 1Y
- 29.56%
- 3Y*
- 16.24%
- 5Y*
- 10.80%
- 10Y*
- 13.77%
BSX
- 1D
- -0.26%
- 1M
- -9.72%
- YTD
- -49.75%
- 6M
- -48.55%
- 1Y
- -51.29%
- 3Y*
- -1.36%
- 5Y*
- 4.80%
- 10Y*
- 8.35%
FNV.TO vs. BSX - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
FNV.TO Franco-Nevada Corporation | 3.49% | 69.89% | 16.50% | -19.65% | 6.38% | 10.37% | 19.99% | 41.29% | -3.60% | 26.45% |
BSX Boston Scientific Corporation | -49.75% | 1.88% | 67.59% | 21.97% | 15.82% | 18.11% | -22.39% | 22.68% | 54.54% | 6.85% |
Correlation
The correlation between FNV.TO and BSX is -0.02, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | -0.02 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.06 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.12 |
Correlation (10Y) Calculated over the trailing 10-year period | 0.09 |
Correlation (All Time) Calculated using the full available price history since Dec 3, 2007 | 0.05 |
The correlation between FNV.TO and BSX shifts across timeframes, from -0.02 (1 year) to 0.12 (5 years), reflecting how their relationship changes across market environments.
Fundamentals
FNV.TO:
CA$56.67B
BSX:
$70.13B
FNV.TO:
$7.09
BSX:
$2.38
FNV.TO:
29.59
BSX:
19.74
FNV.TO:
0.62
BSX:
0.44
FNV.TO:
19.27
BSX:
3.40
FNV.TO:
5.00
BSX:
2.71
FNV.TO:
$2.10B
BSX:
$20.62B
FNV.TO:
$1.61B
BSX:
$14.52B
FNV.TO:
$1.96B
BSX:
$4.76B
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
FNV.TO vs. BSX — Risk / Return Rank
FNV.TO
BSX
FNV.TO vs. BSX - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Franco-Nevada Corporation (FNV.TO) and Boston Scientific Corporation (BSX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| FNV.TO | BSX | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +2.31 | ||
| Sortino ratioReturn per unit of downside risk | +3.43 | ||
| Omega ratioGain probability vs. loss probability | 1.17 | 0.68 | +0.50 |
| Calmar ratioReturn relative to maximum drawdown | 1.23 | -0.92 | +2.15 |
| Martin ratioReturn relative to average drawdown | 3.00 | -1.94 | +4.94 |
Loading charts...
Drawdowns
FNV.TO vs. BSX - Drawdown Comparison
The maximum FNV.TO drawdown since its inception was -47.77%, smaller than the maximum BSX drawdown of -91.92%. Use the drawdown chart below to compare losses from any high point for FNV.TO and BSX.
Loading charts...
Drawdown Indicators
| FNV.TO | BSX | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -47.77% | -91.92% | +44.15% |
Max Drawdown (1Y)Largest decline over 1 year | -24.10% | -56.14% | +32.04% |
Max Drawdown (3Y)Largest decline over 3 years | -27.39% | -56.88% | +29.49% |
Max Drawdown (5Y)Largest decline over 5 years | -33.81% | -56.88% | +23.07% |
Max Drawdown (10Y)Largest decline over 10 years | -38.28% | -56.88% | +18.60% |
Current DrawdownCurrent decline from peak | -23.27% | -56.88% | +33.61% |
Average DrawdownAverage peak-to-trough decline | -12.26% | -47.69% | +35.43% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 9.88% | 26.43% | -16.55% |
Volatility
FNV.TO vs. BSX - Volatility Comparison
The current volatility for Franco-Nevada Corporation (FNV.TO) is 12.29%, while Boston Scientific Corporation (BSX) has a volatility of 16.05%. This indicates that FNV.TO experiences smaller price fluctuations and is considered to be less risky than BSX based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| FNV.TO | BSX | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 12.29% | 16.05% | -3.76% |
Volatility (6M)Calculated over the trailing 6-month period | 29.14% | 33.04% | -3.90% |
Volatility (1Y)Calculated over the trailing 1-year period | 35.12% | 35.05% | +0.07% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 28.39% | 26.21% | +2.18% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 28.81% | 27.81% | +1.00% |
Dividends
FNV.TO vs. BSX - Dividend Comparison
FNV.TO's dividend yield for the trailing twelve months is around 0.77%, while BSX has not paid dividends to shareholders.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
BSX Boston Scientific Corporation | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
FNV.TO Franco-Nevada Corporation | 0.77% | 0.74% | 1.17% | 1.25% | 0.81% | 0.66% | 0.86% | 0.74% | 1.07% | 0.98% | 1.08% | 1.42% |
Financials
FNV.TO vs. BSX - Financials Comparison
This section allows you to compare key financial metrics between Franco-Nevada Corporation and Boston Scientific Corporation. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
FNV.TO vs. BSX - Profitability Comparison
FNV.TO - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Franco-Nevada Corporation reported a gross profit of 517.08M and revenue of 639.45M. Therefore, the gross margin over that period was 80.9%.
BSX - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Boston Scientific Corporation reported a gross profit of 3.61B and revenue of 5.20B. Therefore, the gross margin over that period was 69.4%.
FNV.TO - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Franco-Nevada Corporation reported an operating income of 501.94M and revenue of 639.45M, resulting in an operating margin of 78.5%.
BSX - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Boston Scientific Corporation reported an operating income of 1.07B and revenue of 5.20B, resulting in an operating margin of 20.6%.
FNV.TO - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Franco-Nevada Corporation reported a net income of 460.92M and revenue of 639.45M, resulting in a net margin of 72.1%.
BSX - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Boston Scientific Corporation reported a net income of 1.34B and revenue of 5.20B, resulting in a net margin of 25.7%.
Frequently Asked Questions
FNV.TO and BSX have a correlation of -0.02, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
Find the right allocation for FNV.TO and BSX
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer